Pharmaceutical Supply Chain Management

The presentation will cover how to establish good supply chain procedures and what to seek in such a system. This webinar will include the FDA’s recent guidance document on supply chain for Compounding Pharmacies and how others can use these same standards.

Courtland Imel
Instructor:
Courtland Imel
Date:
Thursday, March 19, 2020
Time:
10:00 AM PST | 01:00 PM EST
Duration:
60 Minutes

More Trainings by this Expert   Product Id : 502882

Price Details
$150 Live
$290 Corporate Live
$190 Recorded
$390 Corporate Recorded
Combo Offers
Live + Recorded
$289 $340 Live + Recorded
Corporate (Live + Recorded)
$599 $680 Corporate
(Live + Recorded)
Price Detail Options
Overview:

The presentation will include recent comments by MCA and FDA on the use of criminal supply chains and how to spot them.

The presentation will review the current situation of recent recalls by small firms. The presentation will cover how to establish good supply chain procedures and what to seek in such a system.

The presentation will include FDAs recent guidance document on supply chain for Compounding Pharmacies and how others can use these same standards.

Why should you Attend: Why attend? The major reason for small pharmaceutical companies to enter into a recall situation is the poor quality of raw materials and active ingredients.

Currently, we face issues with generic drug supplies where carcinogens appear in our blood pressure medications, affecting millions of us.

Compounding pharmacies, generic firms, and small pharmaceutical companies struggle with adequate and compliant supply chain. In addition, many firms suffer from the criminal suppliers. Both MCA and FDA warn firms about the potential use.

Areas Covered in the Session:

  • Criminals in Supply Chain Management
  • FDA and MCA comments on criminal activities
  • Recent Recalls due to lack of supply chain management
  • Proper testing requirements
  • How to avoid a recall due to supply chain

Who Will Benefit:
  • Quality
  • Manufacturing
  • Regulatory Affairs
  • QA/QC/RA
  • R&D
  • Supply Chain
  • Purchasing


Speaker Profile
Courtland Imel is CEO of Ceutical Laboratories. Courtland has provided training to FDA, Health Canada, and state regulatory authorities. Courtland has spoken at AFDO, AFDOSS, MCAFDO, ASQ, SCC, and Bio. Courtland has 35 years of experience in the industry. Courtland is an SME for several organizations and law firms. Courtland worked for M&M Mars, Allergan, ILEX Oncology, Aronex Pharmaceuticals, Mills Biopharmaceuticals, International Isotopes, Avail Medical Products, Carrington Laboratories, and Ceutical Laboratories, Inc. Courtland has assisted in the submissions of 510Ks, PMAs, IND’s, NDAs, ANDAs, IDEs, and more.

Ceutical Labs provides many services including product development, formulation development, analytical testing (chemistry, microbiology, and physical), regulatory submissions, electronic submissions, consulting, training, quality systems, and more.


You Recently Viewed